APA (7th ed.) Citation

WY, H., CL, Y., CC, L., YR, T., CY, C., CC, H., . . . CH, C. (2022). Use of fibrates is not associated with reduced risks of mortality or cardiovascular events among ESRD patients: A national cohort study. Frontiers in cardiovascular medicine, 9, 907539. https://doi.org/10.3389/fcvm.2022.907539

Chicago Style (17th ed.) Citation

WY, Ho, et al. "Use of Fibrates Is Not Associated with Reduced Risks of Mortality or Cardiovascular Events Among ESRD Patients: A National Cohort Study." Frontiers in Cardiovascular Medicine 9 (2022): 907539. https://doi.org/10.3389/fcvm.2022.907539.

MLA (9th ed.) Citation

WY, Ho, et al. "Use of Fibrates Is Not Associated with Reduced Risks of Mortality or Cardiovascular Events Among ESRD Patients: A National Cohort Study." Frontiers in Cardiovascular Medicine, vol. 9, 2022, p. 907539, https://doi.org/10.3389/fcvm.2022.907539.